Jim Cramer Recently Discussed These 7 Stocks

5. Haleon plc (NYSE:HLN)

Number of Hedge Fund Holders: 21

Haleon plc (NYSE:HLN) is one of the stocks Jim Cramer recently discussed. Cramer highlighted the stock’s struggles, as he commented:

“With Kimberly-Clark shelling out nearly $49 billion to buy Kenvue, which was originally J&J’s over-the-counter medicine business, I think it’s time to check in with Haleon, the former consumer business of GlaxoSmithKline and Pfizer… Oh, they’ve got a ton of big brands, and you know them all: Advil, Sensodyne, Theraflu, among many others. But the stock’s been struggling, pulling back from the north of $11 in June to $9 and change as of today. Hey, late last week, Haleon reported, and the results were generally in line with expectations, a slightly better-than-expected 3.4% organic revenue growth. The company seems to be in a tough space in North America… but they’ve got terrific growth, Latin America, I like India, really some great overseas.”

Haleon plc (NYSE:HLN) develops consumer healthcare products across oral care, pain relief, respiratory, digestive health, and supplements.